PB1899: DEVELOPMENT AND VALIDATION OF A PREDICTIVE SCORING SYSTEM FOR THE PROGNOSIS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) IN CHRONIC PHASE RECEIVING FIRST-LINE IMATINIB

• M. Bektaş,
• A. E. Eşkazan,
• T. O. Tiryaki,
• R. Mullai,
• T. Elverdi,
• A. Salihoğlu,
• M. Tiribelli,
• M. C. Ar,
• S. Öngören,
• Z. Başlar,
• M. Nalçaci,
• T. Soysal

Affiliations

M. Bektaş

1 Department of Internal Medicine

A. E. Eşkazan

2 Department of Internal Medicine, Division of Hematology, Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine

T. O. Tiryaki

3 Department of Internal Medicine, Division of Hematology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey

R. Mullai

4 Division of Hematology and BMT, University of Udine, Udine, Italy

T. Elverdi

2 Department of Internal Medicine, Division of Hematology, Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine

A. Salihoğlu

2 Department of Internal Medicine, Division of Hematology, Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine

M. Tiribelli

4 Division of Hematology and BMT, University of Udine, Udine, Italy

M. C. Ar

2 Department of Internal Medicine, Division of Hematology, Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine

S. Öngören

2 Department of Internal Medicine, Division of Hematology, Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine

Z. Başlar

2 Department of Internal Medicine, Division of Hematology, Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine

M. Nalçaci

3 Department of Internal Medicine, Division of Hematology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey

T. Soysal

2 Department of Internal Medicine, Division of Hematology, Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine